Sulfolane has been found as a ground water contaminant near refining sites. These studies investigated the in vitro hepatic clearance and in vivo disposition of [14C]sulfolane in rats and mice following a single oral administration (30, 100, or 300 mg/kg) and dermal application (100 mg/kg).[14C]Sulfolane was well-absorbed in male rats following oral administration and excreted extensively in urine (≥93%). Total radioactivity in tissues at 24 and 48 h was ∼7% and <2%. Disposition pattern was similar in female rats and male and female mice at 100 mg/kg oral dose.Dermally applied [14C]Sulfolane (covered dose site, 100 mg/kg) was poorly absorbed in male (∼16%) and female (∼19%) rats; absorption increased to 59% when the dose site was uncovered in male rats suggesting ingestion of dose via grooming of the dose site. Dermally applied [14C]sulfolane (100 mg/kg, covered dose site) was well absorbed in male (∼70%) and female (∼80%) mice.Urinary radiochemical profiles were similar between routes, species, and sexes; the main analytes present in urine were sulfolane and 3-hydroxysulfolane.Sulfolane was not cleared in hepatocytes from rodents or human suggesting sites other than liver might be involved in metabolism of sulfolane in vivo.
Sulfolane has been foun class="Disease">nd as a groundwater contaminant near refining sites. These studies investigated the in vitro hepatic clearance and in vivo disposition of [14C]sulfolane in rats andmice following a single oral administration (30, 100, or 300 mg/kg) and dermal application (100 mg/kg).[14C]Sulfolane was well-absorbed in male rats following oral administration and excreted extensively in urine (≥93%). Total radioactivity in tissues at 24 and 48 h was ∼7% and <2%. Disposition pattern was similar in female rats and male and female mice at 100 mg/kg oral dose.Dermally applied [14C]Sulfolane (covered dose site, 100 mg/kg) was poorly absorbed in male (∼16%) and female (∼19%) rats; absorption increased to 59% when the dose site was uncovered in male rats suggesting ingestion of dose via grooming of the dose site. Dermally applied [14C]sulfolane (100 mg/kg, covered dose site) was well absorbed in male (∼70%) and female (∼80%) mice.Urinary radiochemical profiles were similar between routes, species, and sexes; the main analytes present in urine were sulfolane and3-hydroxysulfolane.Sulfolane was not cleared in hepatocytes from rodents or human suggesting sites other than liver might be involved in metabolism of sulfolane in vivo.
Authors: Daniel R Oros; Walter M Jarman; Theresa Lowe; Nicole David; Sarah Lowe; Jay A Davis Journal: Mar Pollut Bull Date: 2003-09 Impact factor: 5.553
Authors: Mary A Soliman; Joel A Pedersen; Heesu Park; Angelica Castaneda-Jimenez; Michael K Stenstrom; I H Mel Suffet Journal: Water Environ Res Date: 2007-02 Impact factor: 1.946
Authors: Suramya Waidyanatha; Sherry R Black; Rodney W Snyder; Yun Lan Yueh; Vicki Sutherland; Purvi R Patel; Scott L Watson; Timothy R Fennell Journal: Toxicol Appl Pharmacol Date: 2018-05-18 Impact factor: 4.219
Authors: Esra Mutlu; C Edwin Garner; Christopher J Wegerski; Jacob D McDonald; Barry S McIntyre; Melanie Doyle-Eisele; Suramya Waidyanatha Journal: Xenobiotica Date: 2019-10-31 Impact factor: 1.908
Authors: Suramya Waidyanatha; Sherry R Black; Purvi R Patel; Scott L Watson; Rodney W Snyder; Vicki Sutherland; Jason Stanko; Timothy R Fennell Journal: Xenobiotica Date: 2020-06-24 Impact factor: 1.908
Authors: Suramya Waidyanatha; Sherry R Black; Timothy R Fennell; Scott L Watson; Purvi R Patel; Stephen D Cooper; James Blake; Veronica Godfrey Robinson; Reshan A Fernando; Chad R Blystone Journal: Toxicol Appl Pharmacol Date: 2019-07-22 Impact factor: 4.219
Authors: AtLee T D Watson; Benjamin C Moeller; Melanie Doyle-Eisele; Edwin Garner; Chad R Blystone; Jacob D McDonald; Suramya Waidyanatha Journal: Xenobiotica Date: 2021-03-26 Impact factor: 1.997
Authors: K A Shipkowski; M C Cora; M F Cesta; V G Robinson; S Waidyanatha; K L Witt; M K Vallant; D M Fallacara; M R Hejtmancik; S A Masten; S D Cooper; R A Fernando; C R Blystone Journal: Toxicol Rep Date: 2021-02-06
Authors: AtLee T D Watson; Victor J Johnson; Michael I Luster; Gary R Burleson; Dawn M Fallacara; Barney R Sparrow; Mark F Cesta; Michelle C Cora; Keith R Shockley; Matt D Stout; Chad R Blystone; Dori R Germolec Journal: J Immunotoxicol Date: 2021-12 Impact factor: 3.000